AskNiveshLive·11:27 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to JAGSNPHARM

Jagsonpal Pharmaceuticals Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
5976757364
Other income
33333
Expenses
5264615956
Cost of materials consumed
45443
Purchases of stock-in-trade
1823242320
Change in inventories
0.70-1-0.40-0.300.90
Employee benefit expense
1719181816
Finance costs
0.300.200.300.300.20
Depreciation & amortisation
22222
Other expenses
1215131314
EBITDA
1117201714
EBIT
915171512
Exceptional items
-0.20---2-
Profit Before Tax
914171512
Tax expense
24443
Deferred tax
0.900.500.40-0.200.50
Net Profit
71113119
Financial Ratios
Operating Profit Margin
15.36%19.31%22.95%20.30%18.69%
EBITDA Margin
19.28%22.49%26.17%23.59%22.27%
Net Profit Margin
11.26%14.29%16.91%14.95%13.71%
Earnings Per Share (₹)
0.981.601.881.671.25

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.